Nov
16th
Sun
16th
Nov. 17 (Bloomberg) — Jack Rosser’s doctor says taking Pfizer Inc.’s Sutent cancer drug may keep him alive long enough to see his 1-year-old daughter, Emma, enter primary school. The U.K.’s National Health Service says that’s not worth the expense.
—
Bloomberg.com: Cancer Patients Lose Chance of Longer Life as U.K. Curbs Costs
To all of you who are into nationalized healthcare, doesn’t this just mess up your mind? Turns out, the world of cost-benefit analysis and the reality of scarce goods/choices isn’t confined to the private sector.
Imagine if John Edwards were campaigning in the UK. He wouldn’t be able to blame ‘corporate greed’ everytime someone didn’t get the coverage they wanted. What would he say? Probably something like NHS ennificiency, or somesuch nonsense.
